Back to RARE
TWO SIGMA INVESTMENTS, LP → RARE
TWO SIGMA INVESTMENTS, LP RARE Position History
Ultragenyx Pharmaceutical Inc. • Healthcare
Quarters held
14
Latest value
$120.9M
Q2 2026
Peak value
$120.9M
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $19.6M |
| Q2 2023 | $18.6M |
| Q3 2023 | $1.4M |
| Q4 2023 | $6.1M |
| Q1 2024 | $19.4M |
| Q2 2024 | $23.4M |
| Q3 2024 | $42M |
| Q4 2024 | $25.9M |
| Q1 2025 | $22.9M |
| Q2 2025 | $21M |
| Q3 2025 | $9.8M |
| Q4 2025 | $9.8M |
| Q1 2026 | $46.2M |
| Q2 2026 | $120.9M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $120.9M | 3.62M | — | — |
| Q1 2026 | $46.2M | 2.21M | — | — |
| Q4 2025 | $9.8M | 424.0K | — | — |
| Q3 2025 | $9.8M | 326.2K | — | — |
| Q2 2025 | $21M | 576.9K | — | — |
| Q1 2025 | $22.9M | 633.2K | — | — |
| Q4 2024 | $25.9M | 614.9K | — | — |
| Q3 2024 | $42M | 755.7K | — | — |
| Q2 2024 | $23.4M | 568.3K | — | — |
| Q1 2024 | $19.4M | 415.3K | — | — |
| Q4 2023 | $6.1M | 126.6K | — | — |
| Q3 2023 | $1.4M | 39.2K | — | — |
| Q2 2023 | $18.6M | 403.8K | — | — |
| Q1 2023 | $19.6M | 488.4K | — | — |
Other funds holding RARE
$365.5M
$356.7M
$283.9M
$219.1M
$213.3M
$205.6M
$205.6M